126 related articles for article (PubMed ID: 15597346)
21. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
[TBL] [Abstract][Full Text] [Related]
22. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease.
Gibson PR; Weston AR; Shann A; Florin TH; Lawrance IC; Macrae FA; Radford-Smith G
J Gastroenterol Hepatol; 2007 Aug; 22(8):1306-12. PubMed ID: 17559375
[TBL] [Abstract][Full Text] [Related]
23. [A comparative study of induction of remission and cost-effectiveness of enteral nutrition versus infliximab in moderate-to-severe Crohn's disease].
Zhu WM; Zuo LG; Li Y; Cao L; Zhang W; Gu YF; Xu M; Li N; Li JS
Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):721-5. PubMed ID: 24314158
[TBL] [Abstract][Full Text] [Related]
24. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition.
Afzal NA; Van Der Zaag-Loonen HJ; Arnaud-Battandier F; Davies S; Murch S; Derkx B; Heuschkel R; Fell JM
Aliment Pharmacol Ther; 2004 Jul; 20(2):167-72. PubMed ID: 15233696
[TBL] [Abstract][Full Text] [Related]
25. Development of granulocyte and monocyte adsorptive apheresis in the rat dextran sodium sulfate-induced colitis model.
Tomiyasu N; Mitsuyama K; Suzuki A; Masuda J; Yamasaki H; Kuwaki K; Takaki K; Kitazaki S; Sata M
Methods Find Exp Clin Pharmacol; 2007 May; 29(4):265-8. PubMed ID: 17609738
[TBL] [Abstract][Full Text] [Related]
26. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy of infliximab on active Crohn's disease under nutritional therapy.
Matsumoto T; Iida M; Kohgo Y; Imamura A; Kusugami K; Nakano H; Fujiyama Y; Matsu T; Hibi T
Scand J Gastroenterol; 2005 Dec; 40(12):1423-30. PubMed ID: 16316890
[TBL] [Abstract][Full Text] [Related]
30. An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease.
Yoshimura N; Yokoyama Y; Matsuoka K; Takahashi H; Iwakiri R; Yamamoto T; Nakagawa T; Fukuchi T; Motoya S; Kunisaki R; Kato S; Hirai F; Ishiguro Y; Tanida S; Hiraoka S; Mitsuyama K; Ishihara S; Tanaka S; Otaka M; Osada T; Kagaya T; Suzuki Y; Nakase H; Hanai H; Watanabe K; Kashiwagi N; Hibi T
BMC Gastroenterol; 2015 Nov; 15():163. PubMed ID: 26585569
[TBL] [Abstract][Full Text] [Related]
31. Immunoregulatory effects of adsorptive granulocyte and monocyte apheresis in patients with drug refractory Crohn's disease.
Nagase K; Fukunaga K; Kashiwamura S; Kono T; Kamikozuru K; Yokoyama Y; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kikuyama R; Kato K; Miwa H; Matsumoto T
Ther Apher Dial; 2011 Aug; 15(4):367-73. PubMed ID: 21884471
[TBL] [Abstract][Full Text] [Related]
32. Enteral nutrition improves health-related quality of life in Crohn's disease patients with long disease duration.
Kuriyama M; Kato J; Morimoto N; Fujimoto T; Kono H; Okano N; Miyaike J; Morita T; Okada H; Suzuki S; Yoshioka T; Shiode J; Shiratori Y; Kazuhide Y;
Hepatogastroenterology; 2009; 56(90):321-7. PubMed ID: 19579591
[TBL] [Abstract][Full Text] [Related]
33. Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion.
Kasparek MS; Glatzle J; Temeltcheva T; Mueller MH; Koenigsrainer A; Kreis ME
Dis Colon Rectum; 2007 Dec; 50(12):2067-74. PubMed ID: 17680311
[TBL] [Abstract][Full Text] [Related]
34. Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy.
Fukunaga K; Fukuda Y; Sawada K; Hori K; Matoba Y; Sagayama K; Ohnishi K; Fukui S; Shimoyama T
J Gastroenterol; 2003; 38(7):684-9. PubMed ID: 12898362
[TBL] [Abstract][Full Text] [Related]
35. [Granulocytapheresis in inflammatory bowel disease. Efficacy of an induction plus maintenance sessions protocol at 32 weeks].
Fernández Pérez FJ; Rodríguez F; de Sola C; Fernández Moreno N; Vera F; Rivera R; Sánchez Cantos A
Rev Esp Enferm Dig; 2007 Nov; 99(11):628-35. PubMed ID: 18271660
[TBL] [Abstract][Full Text] [Related]
36. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
[TBL] [Abstract][Full Text] [Related]
37. Correlation between disease activity and arterial blood pressure in Crohn's disease.
Koga H; Iida M; Matsumoto T; Aoyagi K; Fujishima M
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):787-91. PubMed ID: 8864676
[TBL] [Abstract][Full Text] [Related]
38. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial.
Ludvigsson JF; Krantz M; Bodin L; Stenhammar L; Lindquist B
Acta Paediatr; 2004 Mar; 93(3):327-35. PubMed ID: 15124834
[TBL] [Abstract][Full Text] [Related]
39. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
[TBL] [Abstract][Full Text] [Related]
40. Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease.
Inoue S; Nakase H; Matsuura M; Ueno S; Uza N; Kitamura H; Mikami S; Tamaki H; Kasahara K; Chiba T
J Gastroenterol Hepatol; 2007 Jul; 22(7):984-8. PubMed ID: 17608842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
